Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay.

about

Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay.

Item

http://www.wikidata.org/entity/Q55230268

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Integrated DNA/RNA targeted ge ...... mphoma using a clinical assay.

@en

Integrated DNA/RNA targeted ge ...... mphoma using a clinical assay.

@nl

type

Item

label

Integrated DNA/RNA targeted ge ...... mphoma using a clinical assay.

@en

Integrated DNA/RNA targeted ge ...... mphoma using a clinical assay.

@nl

prefLabel

Integrated DNA/RNA targeted ge ...... mphoma using a clinical assay.

@en

Integrated DNA/RNA targeted ge ...... mphoma using a clinical assay.

@nl

P1476

Integrated DNA/RNA targeted ge ...... mphoma using a clinical assay.

@en

P2093

Ahmet Dogan

http://www.w3.org/2001/XMLSchema#string

Alison Moskowitz

http://www.w3.org/2001/XMLSchema#string

Amanda R Copeland

http://www.w3.org/2001/XMLSchema#string

Anas Younes

http://www.w3.org/2001/XMLSchema#string

Andrew D Zelenetz

http://www.w3.org/2001/XMLSchema#string

Anita Kumar

http://www.w3.org/2001/XMLSchema#string

Ariela Noy

http://www.w3.org/2001/XMLSchema#string

Carol Portlock

http://www.w3.org/2001/XMLSchema#string

Connie L Batlevi

http://www.w3.org/2001/XMLSchema#string

Craig H Moskowitz

http://www.w3.org/2001/XMLSchema#string

P2860

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond

Oncogenically active MYD88 mutations in human lymphoma

Analysis of the coding genome of diffuse large B-cell lymphoma

Histone deacetylase inhibitors in cancer therapy.

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

Genetic heterogeneity of diffuse large B-cell lymphoma

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

P2888

s41408-018-0089-0

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41408-018-0089-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1104509157

http://www.w3.org/2001/XMLSchema#string

P698

29895903

http://www.w3.org/2001/XMLSchema#string

P932

5997645

http://www.w3.org/2001/XMLSchema#string